Schilling, W., Jittamala, P., Watson, J., Ekkapongpisit, M., Siripoon, T., Ngamprasertchai, T., . . . Group, P. C. (2023). Pharmacometrics of high dose ivermectin in early COVID-19: An open label, randomized, controlled adaptive platform trial (PLATCOV). eLife Sciences Publications.
Chicago Style (17th ed.) CitationSchilling, WHK, et al. Pharmacometrics of High Dose Ivermectin in Early COVID-19: An Open Label, Randomized, Controlled Adaptive Platform Trial (PLATCOV). eLife Sciences Publications, 2023.
MLA引文Schilling, WHK, et al. Pharmacometrics of High Dose Ivermectin in Early COVID-19: An Open Label, Randomized, Controlled Adaptive Platform Trial (PLATCOV). eLife Sciences Publications, 2023.
警告：這些引文格式不一定是100％准確.